BRITTANY HILL: Open Payments
NPI 1497258685 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,220 in 89 payments from 20 companies in 2025. Trend: 2023 $275 · 2024 $634 · 2025 $1,220
Food & beverage: $1,220
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 17 | $232 |
| PFIZER INC. | 28 | $222 |
| AstraZeneca Pharmaceuticals LP | 5 | $150 |
| GlaxoSmithKline, LLC. | 11 | $135 |
| Sumitomo Pharma America, Inc. | 3 | $56 |
| Novo Nordisk Inc | 3 | $54 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $53 |
| Amgen Inc. | 3 | $46 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $43 |
| Abbott Laboratories | 2 | $32 |
Products named: MOUNJARO, BREZTRI, JARDIANCE, ELIQUIS, TRELEGY ELLIPTA, NURTEC ODT, PREVNAR 20, GEMTESA.
Industry payments across KS — which companies pay providers there.
